US neurobehavioral health company BlackThorn raises $76m to advance AI-driven targeted therapeutics

pharmanewsdaily- June 14, 2019 0

California-based neurobehavioral health company BlackThorn Therapeutics has raised $76 million through a Series B financing round to advance targeted therapeutics using the next-generation artificial intelligence ... Read More